Clinical Trial Update: A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating VEPEMB in patients with Hodgkin lymphoma aged 60 years and older has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• VEPEMB

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Lymphoma | Phase 2 | Status: COMPLETED